Oxford BioDynamics (LON:OBD) Stock Price Down 6.7% – Should You Sell?

Oxford BioDynamics Plc (LON:OBD)’s share price fell 6.7% during trading on Thursday . The company traded as low as GBX 1.30 ($0.02) and last traded at GBX 1.40 ($0.02). 677,375 shares changed hands during trading, a decline of 64% from the average session volume of 1,873,925 shares. The stock had previously closed at GBX 1.50 ($0.02).

Oxford BioDynamics Stock Performance

The business has a fifty day simple moving average of GBX 1.27 and a two-hundred day simple moving average of GBX 4.16. The company has a market cap of £4.37 million, a P/E ratio of -23.33 and a beta of 0.42. The company has a quick ratio of 2.80, a current ratio of 0.68 and a debt-to-equity ratio of 370.22.

Insiders Place Their Bets

In other news, insider David Holbrook bought 49,653 shares of the stock in a transaction that occurred on Monday, October 28th. The shares were bought at an average price of GBX 1 ($0.01) per share, for a total transaction of £496.53 ($621.28). Insiders own 16.78% of the company’s stock.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.